Fredun Pharmaceuticals Allots 182,400 Equity Shares Post Warrant Conversion
Fredun Pharmaceuticals Ltd 路 Outcome 路 06 Oct 2026, 1:50 am
Fredun Pharmaceuticals Allots 182,400 Equity Shares Post Warrant Conversion Fredun Pharmaceuticals approved the allotment of 1,82,400 fully paid-up equity shares (face value Rs. 10 each) on 3rd Oct'26, pursuant to the conversion of 60,800 preferential warrants across 10 non-promoter allottees following receipt of the balance consideration. Originally allotted on 29th Dec'25 at an issue price of Rs. 1,250 per warrant, the conversion ratio was adjusted to three equity shares per warrant following the company's 1:2 bonus issue. Post-allotment, 2,667 warrants remain outstanding for future conversion. The allotted shares rank pari passu with existing equity.
Original exchange filing (PDF)
More announcements from Fredun Pharmaceuticals Ltd
- Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited. 路 16 Nov 2026
- Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 路 14 Nov 2026
- Report of Monitoring Agency on the use of proceeds raised through Preferential Allotment for the quarters ended March 31, 2026, June 30,2026 and September30, 2026. 路 14 Nov 2026
- Statement of Deviation or Variation For the Quarter Ended September 30, 2026 for the Funds raised through Preferential Issue. 路 14 Nov 2026
- Intimation of Earnings Conference Call for the Quarter Q2 of FY27 路 16 Nov 2026
- Press Release 路 06 Nov 2026
- Approval for National Stock Exchange of India Limited (NSE) Listing Application. 路 05 Nov 2026
- Financial results for the quarter ended 30th September, 2026. 路 05 Nov 2026
